Contract facts
FederalNo full NAICS 621511 intel page yet. Browse NAICS intelligence
COVID-19 TESTING is a federal award for Usp Atlanta held by Quest Diagnostics Inc. Estimated value $198K ($35K obligated). Current period of performance ends Mar 30, 2022. Last award drew 1 bidder. Place of performance: COLLEGEVILLE PA.
Recompete timing
PublicCurrent PoP ended Mar 30, 2022 (1605 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordQuest Diagnostics Inc — $202.6M obligated across 1,625 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15B30121FWB130038?
15B30121FWB130038 (Covid-19 testing) is a Usp Atlanta award with a potential value of $198K, currently held by Quest Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15B30121FWB130038?
Usp Atlanta awarded 15B30121FWB130038 to Quest Diagnostics Inc (potential $198K).
Who is the incumbent on 15B30121FWB130038?
Quest Diagnostics Inc is the incumbent with $202.6M across 1625 related awards in SCOUT’s public footprint. The current period of performance ends Mar 30, 2022.
When does Quest Diagnostics Inc’s 15B30121FWB130038 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
